Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A school-based survey of students in Berkshire, Buckinghamshire, Gloucestershire, Oxfordshire and Wiltshire examined over 200 key factors in the lives and expectations of young people, aged 8-18 years, helping to shed light on mental health during lockdown.

Student working at desk with laptop

The Oxford University-led study included 19,000 students from 237 schools across Berkshire East, Berkshire West, Buckinghamshire, Gloucestershire, Oxfordshire, South Gloucestershire, and Wiltshire. Students in Years 4 to 13 (aged 8-18 years) completed the OxWell School Survey 2020, either while at school or at home. The survey assessed mental wellbeing, anxiety, indicators of vulnerability, sleep patterns, online safety, and protective factors, such as exercise, social interaction, and attitudes to accessing mental health support.

The analysis of results from the survey findings is on-going, however early reports suggest that older students were more likely to perceive their mental wellbeing as being lower during lockdown compared with before lockdown, with those in Years 10, 12, and 13 reporting the worst outcomes.

The full story is available on the University of Oxford website

Similar stories

COVID-19 increased public trust in science, new survey shows

A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.

Major funding for Oxford will help find new cancer treatments

Cancer Research UK and the National Institute for Health and Care Research are investing over £3 million across the next five years into The University of Oxford’s Experimental Cancer Medicine Centre (ECMC). The investment will enable Oxford to expand its portfolio of precision prevention and early detection cancer trials.

New study reveals role of lymphatic system in bone healing

It was previously assumed that bones lacked lymphatic vessels, but new research from the MRC Human Immunology Unit at Oxford's MRC Weatherall Institute for Molecular Medicine not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.

Vaccination shown to protect against pregnancy complications from COVID-19 Omicron variant

The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has today published, in The Lancet, the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries.

Molnupiravir doesn't reduce COVID-19 hospitalisations in high-risk vaccinated people

Researchers from the University of Oxford released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 – the first treatment tested in the ongoing PANORAMIC trial. In their paper published in The Lancet, they reported that molnupiravir did not reduce hospitalisations or deaths among higher risk, vaccinated adults with COVID-19 in the community.

Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment

New research from the MRC Weatherall Institute of Molecular Medicine has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.